SlideShare a Scribd company logo
1 of 20
Cytogeneticmolecular of cancer Google.images. SNEIDER ALEXANDER TORRES SOTO                                 BIOLOGY MOLECULAR UPB-MEDELLIN
FOLDING
FOLDING
INTRODUCTION The cytogeneticsis the study of chromosomes in number and in structure,  The main technique for humancytogeneticsstudyisrepresented by fluorescence in situ hybridization (FISH), whichisconsidered a technique thatrevolutionized the chromosome analysis in humancytogenetics and emerges as a promising technique in the fieldclinicalgenetics, clinicaloncology and clinicalresearchs.
The investigation is to ascertain whether the suppression of chromosome 9p in clear cell renal carcinoma (ccRCC) predicts worse disease-specific survival (DSS).
suppression of chromosome 9 Chromosome 9p. ,[object Object],http://dermatology.cdlib.org/
Deletion of chromosome 9p. Deletion of chromosome 9p confers a worse prognosis independent in patients with localized disease ccRCC, and most notably, in patients with localized mass, small kidney
Prevention of carcinoma Histological appearance of renal cell carcinoma the identification of patients with 9p deletions improve risk stratification and help select appropriate patients for surveillance protocols or aggressive treatment. http://escuela.med.puc.cl
Observation . I thinkthatthisstudy has greatclinical application, sinceitallows to determinewhich patients are athighrisk of developingrenal cancer and throughthis to preventdecreasing the morbidity and mortality.
long arm of chromosome 20 is an abnormality of acute myeloid leukemia (AML)and myelodysplastic(MDS) syndrome and is presumed to cause the loss of a tumor suppressor gene in the 20q12.
Tumor suppressor gene Additional copies of chromosome 20 may generate an amplification of the regions of the chromosome where the gene suppressor as in a translocation.
Activation de an oncogen. By RT-PCR has shown a correlation between amplification and increased expression of gen. Localized and high-level amplification of the 250 kb region common is a test for the activation of an oncogene in this region in these cases of MDS and AML.
Tumor suppressor gene ,[object Object],Suppressor gene inactivation Google.images
Observation frommy point of viewthis investigation allows for a more information about acute myeloidleukemiaresulting in a better perspective on this and be able to actat the site of the errorcausing a possible diagnosis.
Citogenetyc Cytogeneticis the branch of geneticthatstudies the diseases of chromosomalinheritanc.
Cytogeneticabnormalities The cytogeneticallowsdetermining the type of chromosomalabnormalityis a diagnostic toolthatallows confirmation of the diagnosis of suchdiseases and also the propergeneticcounseling of patients and theirfamilies ;.
Cytogenetic and cancer The cytogenetic in the cancer represents and avvantadge for a rapidprevention of manydiseases, including cancer recurrentrecurring chromosome in certain malignanttumors
Role of cytogenetics the cytogenetics plays an important role in these two aforementioned pathologies such as leukemia, renal carinomamieloidy and enabling you to identify genetically affected site and provides a pattern in their evolution.
Bibliography  MARTINEZ SÁNCHEZ, Lina  María. Biología molecular. 5. ed. Medellín: UPB. Fac. de Medicina, 2009. 71-72 p.
THANK YOU……………

More Related Content

What's hot

Cells undergoing morphological changes during apoptosis
Cells undergoing morphological changes during apoptosisCells undergoing morphological changes during apoptosis
Cells undergoing morphological changes during apoptosisAnimatedWorld
 
Onocogene and tumor suppressor genes
Onocogene and tumor suppressor genesOnocogene and tumor suppressor genes
Onocogene and tumor suppressor genes9596276530AMIN
 
Oncogene and tumor suppressor gene
Oncogene and tumor suppressor geneOncogene and tumor suppressor gene
Oncogene and tumor suppressor geneAJEESH BL
 
Biology of cancer lecture 5 cell cycle Karobi Moitra
Biology of cancer lecture 5 cell cycle Karobi MoitraBiology of cancer lecture 5 cell cycle Karobi Moitra
Biology of cancer lecture 5 cell cycle Karobi MoitraKarobi Moitra CFD, MS, PhD
 
Tumor suppressor genes
Tumor suppressor genesTumor suppressor genes
Tumor suppressor genesfatmafars
 
The Genetic Basis of Cancer
The Genetic Basis of CancerThe Genetic Basis of Cancer
The Genetic Basis of Cancerbhavishya5
 
Tumor suppressor
Tumor suppressorTumor suppressor
Tumor suppressorfatmafars
 
Dra bartolome's neoplasia review
Dra bartolome's neoplasia reviewDra bartolome's neoplasia review
Dra bartolome's neoplasia reviewyesmin nureja
 
Ascp08 Baltimore
Ascp08 BaltimoreAscp08 Baltimore
Ascp08 BaltimoreML Cohen
 
Tumor supressor genes
Tumor supressor genesTumor supressor genes
Tumor supressor genesVijay Shankar
 
Membranoproliferative glomerulonephritis & c3 glomerulopathy
Membranoproliferative glomerulonephritis & c3 glomerulopathyMembranoproliferative glomerulonephritis & c3 glomerulopathy
Membranoproliferative glomerulonephritis & c3 glomerulopathyscienthiasanjeevani1
 
A draft single-cell atlas of human glioma
A draft single-cell atlas of human gliomaA draft single-cell atlas of human glioma
A draft single-cell atlas of human gliomaAaron Diaz
 
5. tumor suppressor genes dr. sinhasan, mdzah
5. tumor suppressor genes  dr. sinhasan, mdzah5. tumor suppressor genes  dr. sinhasan, mdzah
5. tumor suppressor genes dr. sinhasan, mdzahkciapm
 
ARVO 2015 05042015 FINAL
ARVO 2015 05042015 FINALARVO 2015 05042015 FINAL
ARVO 2015 05042015 FINALMatthew K Zabel
 
Biology of cancer, lecture 2 tumor viruses,oncogenes,tsgs
Biology of cancer, lecture 2 tumor viruses,oncogenes,tsgs Biology of cancer, lecture 2 tumor viruses,oncogenes,tsgs
Biology of cancer, lecture 2 tumor viruses,oncogenes,tsgs Karobi Moitra CFD, MS, PhD
 

What's hot (18)

Cells undergoing morphological changes during apoptosis
Cells undergoing morphological changes during apoptosisCells undergoing morphological changes during apoptosis
Cells undergoing morphological changes during apoptosis
 
Onocogene and tumor suppressor genes
Onocogene and tumor suppressor genesOnocogene and tumor suppressor genes
Onocogene and tumor suppressor genes
 
Apoptosis
Apoptosis Apoptosis
Apoptosis
 
Oncogene and tumor suppressor gene
Oncogene and tumor suppressor geneOncogene and tumor suppressor gene
Oncogene and tumor suppressor gene
 
Biology of cancer lecture 5 cell cycle Karobi Moitra
Biology of cancer lecture 5 cell cycle Karobi MoitraBiology of cancer lecture 5 cell cycle Karobi Moitra
Biology of cancer lecture 5 cell cycle Karobi Moitra
 
Tumor suppressor genes
Tumor suppressor genesTumor suppressor genes
Tumor suppressor genes
 
ONCOGENE AND TUMOUR SUPPRESSOR GENE
ONCOGENE AND TUMOUR SUPPRESSOR GENEONCOGENE AND TUMOUR SUPPRESSOR GENE
ONCOGENE AND TUMOUR SUPPRESSOR GENE
 
The Genetic Basis of Cancer
The Genetic Basis of CancerThe Genetic Basis of Cancer
The Genetic Basis of Cancer
 
Tumor suppressor
Tumor suppressorTumor suppressor
Tumor suppressor
 
Dra bartolome's neoplasia review
Dra bartolome's neoplasia reviewDra bartolome's neoplasia review
Dra bartolome's neoplasia review
 
Ascp08 Baltimore
Ascp08 BaltimoreAscp08 Baltimore
Ascp08 Baltimore
 
Oncogene activation
Oncogene  activationOncogene  activation
Oncogene activation
 
Tumor supressor genes
Tumor supressor genesTumor supressor genes
Tumor supressor genes
 
Membranoproliferative glomerulonephritis & c3 glomerulopathy
Membranoproliferative glomerulonephritis & c3 glomerulopathyMembranoproliferative glomerulonephritis & c3 glomerulopathy
Membranoproliferative glomerulonephritis & c3 glomerulopathy
 
A draft single-cell atlas of human glioma
A draft single-cell atlas of human gliomaA draft single-cell atlas of human glioma
A draft single-cell atlas of human glioma
 
5. tumor suppressor genes dr. sinhasan, mdzah
5. tumor suppressor genes  dr. sinhasan, mdzah5. tumor suppressor genes  dr. sinhasan, mdzah
5. tumor suppressor genes dr. sinhasan, mdzah
 
ARVO 2015 05042015 FINAL
ARVO 2015 05042015 FINALARVO 2015 05042015 FINAL
ARVO 2015 05042015 FINAL
 
Biology of cancer, lecture 2 tumor viruses,oncogenes,tsgs
Biology of cancer, lecture 2 tumor viruses,oncogenes,tsgs Biology of cancer, lecture 2 tumor viruses,oncogenes,tsgs
Biology of cancer, lecture 2 tumor viruses,oncogenes,tsgs
 

Similar to Plegable biology 2

Comparitive genomic hybridisation
Comparitive genomic hybridisationComparitive genomic hybridisation
Comparitive genomic hybridisationnamrathrs87
 
Molecular biology of salivary gland pathology
Molecular biology of salivary gland pathologyMolecular biology of salivary gland pathology
Molecular biology of salivary gland pathologySHREYADAS49
 
Paneles genómicos en tumores sólidos
Paneles genómicos en tumores sólidosPaneles genómicos en tumores sólidos
Paneles genómicos en tumores sólidosMauricio Lema
 
2014-11-17 Taylor Broad Poster FINAL
2014-11-17 Taylor Broad Poster FINAL2014-11-17 Taylor Broad Poster FINAL
2014-11-17 Taylor Broad Poster FINALMichael Cuoco
 
MULTIPROBE FLUORESENCE IN SITU HYBRIDISATION For Detection Of.pptx
MULTIPROBE FLUORESENCE IN SITU HYBRIDISATION For Detection Of.pptxMULTIPROBE FLUORESENCE IN SITU HYBRIDISATION For Detection Of.pptx
MULTIPROBE FLUORESENCE IN SITU HYBRIDISATION For Detection Of.pptxDrmustafa Ali
 
Leukemic stem cells
Leukemic stem cellsLeukemic stem cells
Leukemic stem cellsmds-web
 
بدر الشهاري.ppt
بدر الشهاري.pptبدر الشهاري.ppt
بدر الشهاري.pptosama727046
 
Abstract piis0022202 x1831114x
Abstract piis0022202 x1831114xAbstract piis0022202 x1831114x
Abstract piis0022202 x1831114xWaddah Moghram
 
Fine needle aspiration cytology of neuroendocrine carcinoma of the breast
Fine needle aspiration cytology of neuroendocrine carcinoma of the breastFine needle aspiration cytology of neuroendocrine carcinoma of the breast
Fine needle aspiration cytology of neuroendocrine carcinoma of the breastAbKadir Rifaei Rashid Khairi
 
Genomic oncology and personalized medicine
Genomic oncology and personalized medicine Genomic oncology and personalized medicine
Genomic oncology and personalized medicine C. Jeff Chang, MD, PhD
 
Using biomarkers to monitor the dynamics of tumor
Using biomarkers to monitor the dynamics of tumorUsing biomarkers to monitor the dynamics of tumor
Using biomarkers to monitor the dynamics of tumorsummer elmorshidy
 

Similar to Plegable biology 2 (20)

Comparitive genomic hybridisation
Comparitive genomic hybridisationComparitive genomic hybridisation
Comparitive genomic hybridisation
 
20160218 hisham toma services
20160218 hisham toma services20160218 hisham toma services
20160218 hisham toma services
 
Molecular biology of salivary gland pathology
Molecular biology of salivary gland pathologyMolecular biology of salivary gland pathology
Molecular biology of salivary gland pathology
 
Paneles genómicos en tumores sólidos
Paneles genómicos en tumores sólidosPaneles genómicos en tumores sólidos
Paneles genómicos en tumores sólidos
 
2014-11-17 Taylor Broad Poster FINAL
2014-11-17 Taylor Broad Poster FINAL2014-11-17 Taylor Broad Poster FINAL
2014-11-17 Taylor Broad Poster FINAL
 
MULTIPROBE FLUORESENCE IN SITU HYBRIDISATION For Detection Of.pptx
MULTIPROBE FLUORESENCE IN SITU HYBRIDISATION For Detection Of.pptxMULTIPROBE FLUORESENCE IN SITU HYBRIDISATION For Detection Of.pptx
MULTIPROBE FLUORESENCE IN SITU HYBRIDISATION For Detection Of.pptx
 
Leukemic stem cells
Leukemic stem cellsLeukemic stem cells
Leukemic stem cells
 
بدر الشهاري.ppt
بدر الشهاري.pptبدر الشهاري.ppt
بدر الشهاري.ppt
 
Abstract piis0022202 x1831114x
Abstract piis0022202 x1831114xAbstract piis0022202 x1831114x
Abstract piis0022202 x1831114x
 
Fine needle aspiration cytology of neuroendocrine carcinoma of the breast
Fine needle aspiration cytology of neuroendocrine carcinoma of the breastFine needle aspiration cytology of neuroendocrine carcinoma of the breast
Fine needle aspiration cytology of neuroendocrine carcinoma of the breast
 
Genomic oncology and personalized medicine
Genomic oncology and personalized medicine Genomic oncology and personalized medicine
Genomic oncology and personalized medicine
 
DOOR syndrome
DOOR syndromeDOOR syndrome
DOOR syndrome
 
Cadher
CadherCadher
Cadher
 
Using biomarkers to monitor the dynamics of tumor
Using biomarkers to monitor the dynamics of tumorUsing biomarkers to monitor the dynamics of tumor
Using biomarkers to monitor the dynamics of tumor
 
FISH FISH
FISH FISHFISH FISH
FISH FISH
 
13-chap-24-lecture.ppt
13-chap-24-lecture.ppt13-chap-24-lecture.ppt
13-chap-24-lecture.ppt
 
13-chap-24-lecture.ppt
13-chap-24-lecture.ppt13-chap-24-lecture.ppt
13-chap-24-lecture.ppt
 
13-chap-24-lecture.ppt
13-chap-24-lecture.ppt13-chap-24-lecture.ppt
13-chap-24-lecture.ppt
 
Anticancer.ppt
Anticancer.pptAnticancer.ppt
Anticancer.ppt
 
13-chap-24-lecture.ppt
13-chap-24-lecture.ppt13-chap-24-lecture.ppt
13-chap-24-lecture.ppt
 

Plegable biology 2

  • 1. Cytogeneticmolecular of cancer Google.images. SNEIDER ALEXANDER TORRES SOTO BIOLOGY MOLECULAR UPB-MEDELLIN
  • 4. INTRODUCTION The cytogeneticsis the study of chromosomes in number and in structure, The main technique for humancytogeneticsstudyisrepresented by fluorescence in situ hybridization (FISH), whichisconsidered a technique thatrevolutionized the chromosome analysis in humancytogenetics and emerges as a promising technique in the fieldclinicalgenetics, clinicaloncology and clinicalresearchs.
  • 5. The investigation is to ascertain whether the suppression of chromosome 9p in clear cell renal carcinoma (ccRCC) predicts worse disease-specific survival (DSS).
  • 6.
  • 7. Deletion of chromosome 9p. Deletion of chromosome 9p confers a worse prognosis independent in patients with localized disease ccRCC, and most notably, in patients with localized mass, small kidney
  • 8. Prevention of carcinoma Histological appearance of renal cell carcinoma the identification of patients with 9p deletions improve risk stratification and help select appropriate patients for surveillance protocols or aggressive treatment. http://escuela.med.puc.cl
  • 9. Observation . I thinkthatthisstudy has greatclinical application, sinceitallows to determinewhich patients are athighrisk of developingrenal cancer and throughthis to preventdecreasing the morbidity and mortality.
  • 10. long arm of chromosome 20 is an abnormality of acute myeloid leukemia (AML)and myelodysplastic(MDS) syndrome and is presumed to cause the loss of a tumor suppressor gene in the 20q12.
  • 11. Tumor suppressor gene Additional copies of chromosome 20 may generate an amplification of the regions of the chromosome where the gene suppressor as in a translocation.
  • 12. Activation de an oncogen. By RT-PCR has shown a correlation between amplification and increased expression of gen. Localized and high-level amplification of the 250 kb region common is a test for the activation of an oncogene in this region in these cases of MDS and AML.
  • 13.
  • 14. Observation frommy point of viewthis investigation allows for a more information about acute myeloidleukemiaresulting in a better perspective on this and be able to actat the site of the errorcausing a possible diagnosis.
  • 15. Citogenetyc Cytogeneticis the branch of geneticthatstudies the diseases of chromosomalinheritanc.
  • 16. Cytogeneticabnormalities The cytogeneticallowsdetermining the type of chromosomalabnormalityis a diagnostic toolthatallows confirmation of the diagnosis of suchdiseases and also the propergeneticcounseling of patients and theirfamilies ;.
  • 17. Cytogenetic and cancer The cytogenetic in the cancer represents and avvantadge for a rapidprevention of manydiseases, including cancer recurrentrecurring chromosome in certain malignanttumors
  • 18. Role of cytogenetics the cytogenetics plays an important role in these two aforementioned pathologies such as leukemia, renal carinomamieloidy and enabling you to identify genetically affected site and provides a pattern in their evolution.
  • 19. Bibliography  MARTINEZ SÁNCHEZ, Lina María. Biología molecular. 5. ed. Medellín: UPB. Fac. de Medicina, 2009. 71-72 p.